Taylor-made production of pyrimidine nucleoside-5'-monophosphate analogues by highly stabilized mutant uracil phosphoribosyltransferase from Toxoplasma gondii

dc.contributor.authorAcosta Bueno, Javier
dc.contributor.authorNguyen, Kim
dc.contributor.authorSpitale, Robert C.
dc.contributor.authorFernández Lucas, Jesús
dc.date.accessioned2023-06-07T17:16:11Z
dc.date.available2023-06-07T17:16:11Z
dc.date.issued2021
dc.description.abstractNowadays, enzymatic synthesis of nucleotides is an efficient and sustainable alternative to chemical methodologies. In this regard, after the biochemical characterization of wild-type and mutant uracil phosphoribosyltransferases from Toxoplasma gondii (TgUPRT, TgUPRT2, and TgUPRT3), TgUPRT2 was selected as the optimal candidate (69.5 IU mg-1, UMP synthesis) for structure-guided immobilization onto Ni2+ chelate (MNiUPRT2) and onto glutaraldehyde-activated microparticles (MGlUPRT2). Among resulting derivatives, MNiUPRT23 (6127 IU g-1biocat; 92% retained activity; 3-5 fold enhanced stability at 50-60 °C) and MGlUPRT2N (3711 IU g-1biocat; 27% retained activity; 8-20 fold enhanced stability at 50-60 °C) displayed the best operability. Moreover, the enzymatic synthesis of different pyrimidine NMPs was performed. Finally, the reusability of both derivatives in 5-FUMP synthesis (MNiUPRT23, 80% retained activity after 7 cycles, 5 min; MGlUPRT2N, 70% retained activity after 10 cycles, 20 min) was carried out at short times.spa
dc.description.filiationUEMspa
dc.description.impact11.889 Q1 JCR 2021spa
dc.description.impact2.354 Q1 SJR 2021spa
dc.description.impactNo data IDR 2021spa
dc.description.sponsorshipSantander Foundation (SAN151610)spa
dc.description.sponsorshipUniversidad Europea de Madrid (2020/UEM42)spa
dc.description.sponsorshipNational Institutes of Health (5R21MH116415)spa
dc.identifier.citationAcosta, J., Nguyen, K., Spitale, R. C., & Fernández-Lucas, J. (2021). Taylor-made production of pyrimidine nucleoside-5'-monophosphate analogues by highly stabilized mutant uracil phosphoribosyltransferase from Toxoplasma gondii. Bioresource Technology, 339, 125649. https://doi.org/10.1016/j.biortech.2021.125649spa
dc.identifier.doi10.1016/j.biortech.2021.125649
dc.identifier.issn0960-8524
dc.identifier.issn1873-2976
dc.identifier.urihttp://hdl.handle.net/11268/12123
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1016/j.biortech.2021.125649spa
dc.rights.accessRightsrestricted accessspa
dc.subject.otherNucleósidosspa
dc.subject.unescoBiotecnologíaspa
dc.subject.unescoBioquímicaspa
dc.titleTaylor-made production of pyrimidine nucleoside-5'-monophosphate analogues by highly stabilized mutant uracil phosphoribosyltransferase from Toxoplasma gondiispa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublication9f17496d-ddb2-4712-80ee-0bec353d0a35
relation.isAuthorOfPublication65bdb4fa-7adf-42ce-b40e-421a62e05239
relation.isAuthorOfPublication.latestForDiscovery9f17496d-ddb2-4712-80ee-0bec353d0a35

Files